1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Wang Yingmei: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer LNG-IUS: levonorgestrel intrauterine system, Metformin, Canagliflozin - Endometrioid Endometrial Cancer, Atypical Endometrial Hyperplasia | Phase 2 | Not yet recruiting | Wang Yingmei | 102 | 2027-01-01 | 2026-10-22 |
Canagliflozin (1) · Metformin (1)
China (1)